Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Prostate Cancer Genome Network Wins $20M from Prostate Cancer Canada, OICR

Premium

A new research project called the Canadian Prostate Cancer Genome Network plans to study the genomics of prostate cancer, the International Cancer Genome Consortium said this week.

The network, one of 37 projects conducted under the ICGC's umbrella, is funded with up to CA$15 million ($15.2 million) from Prostate Cancer Canada and CA$5 million ($5.1 million from the Ontario Institute for Cancer Research.

According to the ICGC, it will "map the genetic structure of prostate cancer and provide new information that could greatly improve the diagnosis and treatment of the disease."

The project, dubbed CPC GENE, will be led by Robert Bristow, a senior scientist at the Ontario Cancer Institute, the research arm of the University Health Network's Princess Margaret Hospital, and a genitourinary radiation oncologist at PMH.

It will involve Canadian researchers in Vancouver, Calgary, Toronto, Kingston, and Montreal, who will collaborate with research teams in the UK, France, and Germany.